Investigational Drug Details
| Drug ID: | D024 |
| Drug Name: | AZD4076 |
| Synonyms: | -- |
| Type: | Biological drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | 1967845-94-8 |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | miR-103 antagonist;miR-107 antagonist |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1 completed (NCT02826525) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0111 | NCT02826525 | Phase 1 | Completed | No Results Available | July 18, 2016 | April 1, 2021 | Details |
| L0315 | NCT02612662 | Phase 1 | Active, not recruiting | No Results Available | November 24, 2015 | December 14, 2021 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|